未登录.png)
分享.png)
收藏分享 收藏 分享 收藏 分享 收藏 A 4-weekly course of rituximab is safe and improves tumor control for patients with minimal residual disease persisting 3 months after autologous hematopoietic stem-cell transplantation: results of a prospective multicenter phase II study in patients with follicular lymphoma
Morschhauser, F.; Recher, C.; Milpied, N.; Gressin, R.; Salles, G.; Brice, P.; Vey, N.; Haioun, C.; Colombat, P.; Rossi, J. F.; Deconinck, E.; Lazreg, F.; Bergougnoux, L.; Delsol, G.; Attal, M. 分享 收藏 Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-upColombat, P.; Brousse, N.; Salles, G.; Morschhauser, F.; Brice, P.; Soubeyran, P.; Delwail, V.; Deconinck, E.; Haioun, C.; Foussard, C.; Sebban, C.; Tilly, H.; Thieblemont, C.; Bergougnoux, L.; Lazreg, F.; Solal-Celigny, P. 分享 收藏 Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy贝伐单抗联合化疗一线治疗的转移性乳腺癌患者循环内皮细胞和循环肿瘤细胞的临床价值Bidard, F. -C.; Mathiot, C.; Degeorges, A.; Etienne-Grimaldi, M. -C.; Delva, R.; Pivot, X.; Veyret, C.; Bergougnoux, L.; de Cremoux, P.; Milano, G.; Pierga, J. -Y. 分享 收藏 分享 收藏 分享 收藏 Incidence, Risk Factors and Clinical Consequences of Neutropenia Following Kidney Transplantation: A Retrospective StudyZafrani, L.; Truffaut, L.; Kreis, H.; Etienne, D.; Rafat, C.; Lechaton, S.; Anglicheau, D.; Zuber, J.; Ciroldi, M.; Thervet, E.; Snanoudj, R.; Mamzer, M. F.; Martinez, F.; Timsit, M. O.; Bergougnoux, L.; Legendre, C. 分享 收藏 分享 收藏 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png)
ANNALS OF ONCOLOGY.png)
OAAI